Skip to main content
Equibles
ADTX logo

ADTX · Aditxt, Inc.

Track ADTX — free

Use ADTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 -0.01 (-80.00%) At close · Jun 25
Rebalance outlook locked
Going-concern doubt — flagged May 20, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Because of these factors, we believe that this creates substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed May 20, 2026
Market Cap
$4.99M
Shares
815,921
Volume · Jun 25 362.99M Avg daily vol (27 sessions) 900.84M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.01 Day$0.00–0.01 52W close$0.00–39,785.04 Avg vol 30d810.8M Short int2.2M · 269.5% float · 1.0d Short vol41% DataOct 2024–Jun 2026 Filing10-Q · May 20

Up next

Latest filing: 10-Q
filed May 20, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$14,336
Trailing 12 months
Net income (TTM)
−$53.20M
Trailing 12 months
Revenue growth YoY
+1,094.4%
Year over year
Operating margin
-127,821.4%
Trailing 12 months
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 8,306,454,000.0%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+69,465.5%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▼80% $44,276 −$7.55M '24 Q2 ▼94.5% $6,854 −$12.85M '24 Q3 ▼96.1% $3,175 −$5.23M '24 Q4* ▼98.7% $1,018 −$5.71M '25 Q1 ▼97.7% $1,004 −$7.26M '25 Q2 ▼89.1% $748 −$24.05M '25 Q3 ▼86.6% $425 −$6.09M '25 Q4* LATEST ▲1094.4% $12,159 −$15.95M '26 Q1

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −100%
below
Price vs 50-day avg −100%
below
RSI (14) 14
oversold
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −99%
trailing
6-month return −100%
trailing
YTD return −100%
this year
Relative strength −108%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $3 › 200d $3268 — 200d above 50d
Institutional flow Distributing
-89% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
269.54% of float · ▼ -41.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
Fair
Revenue growth −98%
Y/Y
Gross margin 8%
expanding
EPS growth +100%
Y/Y
Free cash flow $-25.7M
Quant / Vol
risk profile
Very High
Volatility 315%
annualized · 1-yr
Max drawdown −100%
past year
ATR 16790.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
3 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−100% Bearish
Price vs 50-day avg
−100% Bearish
RSI (14)
14 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $3 › 200d $3268 — 200d above 50d
Institutional flow Distributing
-89% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
269.54% of float · ▼ -41.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $39,785
vs 200-day avg -100% vs 50-day avg -100%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ADTX
Aditxt, Inc.
this stock
$4.99M — -97.6% — 269.5%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.07B +13.5% +46.2% 29.9 1.8%
MRNA
Moderna, Inc.
 $96.65B +720.9% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
 $83.13B +4.6% +20.8% 20.0 2.1%
CSLLY
Csl Ltd
 $66.34B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
1
% held
0.0%
Net QoQ
-750 sh
Top holder
IFP Advisors, Inc
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Falling
Shares short
2.2M
Days to cover
1.0d
Change
-1.5M sh
View
Short Volume
Short vol %
41%
As of
Aug 21, 2026
Short Total
View
Fails to Deliver
FTD shares
6.8M
Value
$271.3K
As of
Jun 24, 2026
View
Off-Exchange
Off-exchange %
55.2%
Week of
Jun 22, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$3.2K
Net income (FY)
$-43.1M
EPS diluted
$-31153.41
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 23, 2026
This year
25
View
Exempt Offerings
Offering
$6.0M
Filed
Jan 23, 2024
View

Performance

5D 20D 120D MTD YTD
ADTX -50.0% -99.0% -100.0% -98.3% -100.0%
SPY -0.9% -2.2% +7.7% -2.9% +7.7%
vs SPY -49.1% -96.9% -107.7% -95.4% -107.7%
Key facts CIK 1726711 CUSIP 007025869 Visit website